Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of spontaneous prematurity with josamycin in PCR-positive amniotic fluid
2006-005336-24Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of josamycin in preterm birth, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Preterm delivery between 22 and 37 weeks of gestation. Started Aug 2007; status: active.
02
Drugs
josamycin
03
Conditions
preterm birth
Beyond the preview
Go deeper on 2006-005336-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005336-24.